Priority Date: 20.01.12 (US 201261588959P)
ENHANCED GLYCEMIC CONTROL USING AD36E4ORF1 AND AKT1 INHIBITOR
- Application ID: EP13702690
- Status: █ The patent has been granted
Applicant
Technology Company
Attorney
operating since 1916
Headquarter in The Hague
and
9 offices
active in Legal Services and IP Consulting
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Vereenigde Octrooibureaux NV (V.O.) is specialized in A61. Vereenigde Octrooibureaux NV (V.O.) is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
Timeline
- 20.01.2012 - Priority Date (US 201261588959P)
- 25.07.2013 - Publication A1 (WO2013109876)
- 26.11.2014 - Publication A1 (EP2804616)
- 18.07.2018 - Publication B1 (EP2804616)